Sort by:
Page 64 of 2252246 results

Recent Advances in sMRI and Artificial Intelligence for Presurgical Planning in Focal Cortical Dysplasia: A Systematic Review.

Mahmoudi A, Alizadeh A, Ganji Z, Zare H

pubmed logopapersJun 13 2025
Focal Cortical Dysplasia (FCD) is a leading cause of drug-resistant epilepsy, particularly in children and young adults, necessitating precise presurgical planning. Traditional structural MRI often fails to detect subtle FCD lesions, especially in MRI-negative cases. Recent advancements in Artificial Intelligence (AI), particularly Machine Learning (ML) and Deep Learning (DL), have the potential to enhance FCD detection's sensitivity and specificity. This systematic review, following PRISMA guidelines, searched PubMed, Embase, Scopus, Web of Science, and Science Direct for articles published from 2020 onwards, using keywords related to "Focal Cortical Dysplasia," "MRI," and "Artificial Intelligence/Machine Learning/Deep Learning." Included were original studies employing AI and structural MRI (sMRI) for FCD detection in humans, reporting quantitative performance metrics, and published in English. Data extraction was performed independently by two reviewers, with discrepancies resolved by a third. The included studies demonstrated that AI significantly improved FCD detection, achieving sensitivity up to 97.1% and specificities up to 84.3% across various MRI sequences, including MPRAGE, MP2RAGE, and FLAIR. AI models, particularly deep learning models, matched or surpassed human radiologist performance, with combined AI-human expertise reaching up to 87% detection rates. Among 88 full-text articles reviewed, 27 met inclusion criteria. The studies emphasized the importance of advanced MRI sequences and multimodal MRI for enhanced detection, though model performance varied with FCD type and training datasets. Recent advances in sMRI and AI, especially deep learning, offer substantial potential to improve FCD detection, leading to better presurgical planning and patient outcomes in drug-resistant epilepsy. These methods enable faster, more accurate, and automated FCD detection, potentially enhancing surgical decision-making. Further clinical validation and optimization of AI algorithms across diverse datasets are essential for broader clinical translation.

InceptionMamba: Efficient Multi-Stage Feature Enhancement with Selective State Space Model for Microscopic Medical Image Segmentation

Daniya Najiha Abdul Kareem, Abdul Hannan, Mubashir Noman, Jean Lahoud, Mustansar Fiaz, Hisham Cholakkal

arxiv logopreprintJun 13 2025
Accurate microscopic medical image segmentation plays a crucial role in diagnosing various cancerous cells and identifying tumors. Driven by advancements in deep learning, convolutional neural networks (CNNs) and transformer-based models have been extensively studied to enhance receptive fields and improve medical image segmentation task. However, they often struggle to capture complex cellular and tissue structures in challenging scenarios such as background clutter and object overlap. Moreover, their reliance on the availability of large datasets for improved performance, along with the high computational cost, limit their practicality. To address these issues, we propose an efficient framework for the segmentation task, named InceptionMamba, which encodes multi-stage rich features and offers both performance and computational efficiency. Specifically, we exploit semantic cues to capture both low-frequency and high-frequency regions to enrich the multi-stage features to handle the blurred region boundaries (e.g., cell boundaries). These enriched features are input to a hybrid model that combines an Inception depth-wise convolution with a Mamba block, to maintain high efficiency and capture inherent variations in the scales and shapes of the regions of interest. These enriched features along with low-resolution features are fused to get the final segmentation mask. Our model achieves state-of-the-art performance on two challenging microscopic segmentation datasets (SegPC21 and GlaS) and two skin lesion segmentation datasets (ISIC2017 and ISIC2018), while reducing computational cost by about 5 times compared to the previous best performing method.

MRI-CORE: A Foundation Model for Magnetic Resonance Imaging

Haoyu Dong, Yuwen Chen, Hanxue Gu, Nicholas Konz, Yaqian Chen, Qihang Li, Maciej A. Mazurowski

arxiv logopreprintJun 13 2025
The widespread use of Magnetic Resonance Imaging (MRI) and the rise of deep learning have enabled the development of powerful predictive models for a wide range of diagnostic tasks in MRI, such as image classification or object segmentation. However, training models for specific new tasks often requires large amounts of labeled data, which is difficult to obtain due to high annotation costs and data privacy concerns. To circumvent this issue, we introduce MRI-CORE (MRI COmprehensive Representation Encoder), a vision foundation model pre-trained using more than 6 million slices from over 110,000 MRI volumes across 18 main body locations. Experiments on five diverse object segmentation tasks in MRI demonstrate that MRI-CORE can significantly improve segmentation performance in realistic scenarios with limited labeled data availability, achieving an average gain of 6.97% 3D Dice Coefficient using only 10 annotated slices per task. We further demonstrate new model capabilities in MRI such as classification of image properties including body location, sequence type and institution, and zero-shot segmentation. These results highlight the value of MRI-CORE as a generalist vision foundation model for MRI, potentially lowering the data annotation resource barriers for many applications.

BreastDCEDL: Curating a Comprehensive DCE-MRI Dataset and developing a Transformer Implementation for Breast Cancer Treatment Response Prediction

Naomi Fridman, Bubby Solway, Tomer Fridman, Itamar Barnea, Anat Goldshtein

arxiv logopreprintJun 13 2025
Breast cancer remains a leading cause of cancer-related mortality worldwide, making early detection and accurate treatment response monitoring critical priorities. We present BreastDCEDL, a curated, deep learning-ready dataset comprising pre-treatment 3D Dynamic Contrast-Enhanced MRI (DCE-MRI) scans from 2,070 breast cancer patients drawn from the I-SPY1, I-SPY2, and Duke cohorts, all sourced from The Cancer Imaging Archive. The raw DICOM imaging data were rigorously converted into standardized 3D NIfTI volumes with preserved signal integrity, accompanied by unified tumor annotations and harmonized clinical metadata including pathologic complete response (pCR), hormone receptor (HR), and HER2 status. Although DCE-MRI provides essential diagnostic information and deep learning offers tremendous potential for analyzing such complex data, progress has been limited by lack of accessible, public, multicenter datasets. BreastDCEDL addresses this gap by enabling development of advanced models, including state-of-the-art transformer architectures that require substantial training data. To demonstrate its capacity for robust modeling, we developed the first transformer-based model for breast DCE-MRI, leveraging Vision Transformer (ViT) architecture trained on RGB-fused images from three contrast phases (pre-contrast, early post-contrast, and late post-contrast). Our ViT model achieved state-of-the-art pCR prediction performance in HR+/HER2- patients (AUC 0.94, accuracy 0.93). BreastDCEDL includes predefined benchmark splits, offering a framework for reproducible research and enabling clinically meaningful modeling in breast cancer imaging.

Enhancing Privacy: The Utility of Stand-Alone Synthetic CT and MRI for Tumor and Bone Segmentation

André Ferreira, Kunpeng Xie, Caroline Wilpert, Gustavo Correia, Felix Barajas Ordonez, Tiago Gil Oliveira, Maike Bode, Robert Siepmann, Frank Hölzle, Rainer Röhrig, Jens Kleesiek, Daniel Truhn, Jan Egger, Victor Alves, Behrus Puladi

arxiv logopreprintJun 13 2025
AI requires extensive datasets, while medical data is subject to high data protection. Anonymization is essential, but poses a challenge for some regions, such as the head, as identifying structures overlap with regions of clinical interest. Synthetic data offers a potential solution, but studies often lack rigorous evaluation of realism and utility. Therefore, we investigate to what extent synthetic data can replace real data in segmentation tasks. We employed head and neck cancer CT scans and brain glioma MRI scans from two large datasets. Synthetic data were generated using generative adversarial networks and diffusion models. We evaluated the quality of the synthetic data using MAE, MS-SSIM, Radiomics and a Visual Turing Test (VTT) performed by 5 radiologists and their usefulness in segmentation tasks using DSC. Radiomics indicates high fidelity of synthetic MRIs, but fall short in producing highly realistic CT tissue, with correlation coefficient of 0.8784 and 0.5461 for MRI and CT tumors, respectively. DSC results indicate limited utility of synthetic data: tumor segmentation achieved DSC=0.064 on CT and 0.834 on MRI, while bone segmentation a mean DSC=0.841. Relation between DSC and correlation is observed, but is limited by the complexity of the task. VTT results show synthetic CTs' utility, but with limited educational applications. Synthetic data can be used independently for the segmentation task, although limited by the complexity of the structures to segment. Advancing generative models to better tolerate heterogeneous inputs and learn subtle details is essential for enhancing their realism and expanding their application potential.

BraTS orchestrator : Democratizing and Disseminating state-of-the-art brain tumor image analysis

Florian Kofler, Marcel Rosier, Mehdi Astaraki, Ujjwal Baid, Hendrik Möller, Josef A. Buchner, Felix Steinbauer, Eva Oswald, Ezequiel de la Rosa, Ivan Ezhov, Constantin von See, Jan Kirschke, Anton Schmick, Sarthak Pati, Akis Linardos, Carla Pitarch, Sanyukta Adap, Jeffrey Rudie, Maria Correia de Verdier, Rachit Saluja, Evan Calabrese, Dominic LaBella, Mariam Aboian, Ahmed W. Moawad, Nazanin Maleki, Udunna Anazodo, Maruf Adewole, Marius George Linguraru, Anahita Fathi Kazerooni, Zhifan Jiang, Gian Marco Conte, Hongwei Li, Juan Eugenio Iglesias, Spyridon Bakas, Benedikt Wiestler, Marie Piraud, Bjoern Menze

arxiv logopreprintJun 13 2025
The Brain Tumor Segmentation (BraTS) cluster of challenges has significantly advanced brain tumor image analysis by providing large, curated datasets and addressing clinically relevant tasks. However, despite its success and popularity, algorithms and models developed through BraTS have seen limited adoption in both scientific and clinical communities. To accelerate their dissemination, we introduce BraTS orchestrator, an open-source Python package that provides seamless access to state-of-the-art segmentation and synthesis algorithms for diverse brain tumors from the BraTS challenge ecosystem. Available on GitHub (https://github.com/BrainLesion/BraTS), the package features intuitive tutorials designed for users with minimal programming experience, enabling both researchers and clinicians to easily deploy winning BraTS algorithms for inference. By abstracting the complexities of modern deep learning, BraTS orchestrator democratizes access to the specialized knowledge developed within the BraTS community, making these advances readily available to broader neuro-radiology and neuro-oncology audiences.

Impact of Deep Learning-Based Image Conversion on Fully Automated Coronary Artery Calcium Scoring Using Thin-Slice, Sharp-Kernel, Non-Gated, Low-Dose Chest CT Scans: A Multi-Center Study.

Kim C, Hong S, Choi H, Yoo WS, Kim JY, Chang S, Park CH, Hong SJ, Yang DH, Yong HS, van Assen M, De Cecco CN, Suh YJ

pubmed logopapersJun 13 2025
To evaluate the impact of deep learning-based image conversion on the accuracy of automated coronary artery calcium quantification using thin-slice, sharp-kernel, non-gated, low-dose chest computed tomography (LDCT) images collected from multiple institutions. A total of 225 pairs of LDCT and calcium scoring CT (CSCT) images scanned at 120 kVp and acquired from the same patient within a 6-month interval were retrospectively collected from four institutions. Image conversion was performed for LDCT images using proprietary software programs to simulate conventional CSCT. This process included 1) deep learning-based kernel conversion of low-dose, high-frequency, sharp kernels to simulate standard-dose, low-frequency kernels, and 2) thickness conversion using the raysum method to convert 1-mm or 1.25-mm thickness images to 3-mm thickness. Automated Agaston scoring was conducted on the LDCT scans before (LDCT-Org<sub>auto</sub>) and after the image conversion (LDCT-CONV<sub>auto</sub>). Manual scoring was performed on the CSCT images (CSCT<sub>manual</sub>) and used as a reference standard. The accuracy of automated Agaston scores and risk severity categorization based on the automated scoring on LDCT scans was analyzed compared to the reference standard, using the Bland-Altman analysis, concordance correlation coefficient (CCC), and weighted kappa (κ) statistic. LDCT-CONV<sub>auto</sub> demonstrated a reduced bias for Agaston score, compared with CSCT<sub>manual</sub>, than LDCT-Org<sub>auto</sub> did (-3.45 vs. 206.7). LDCT-CONV<sub>auto</sub> showed a higher CCC than LDCT-Org<sub>auto</sub> did (0.881 [95% confidence interval {CI}, 0.750-0.960] vs. 0.269 [95% CI, 0.129-0.430]). In terms of risk category assignment, LDCT-Org<sub>auto</sub> exhibited poor agreement with CSCT<sub>manual</sub> (weighted κ = 0.115 [95% CI, 0.082-0.154]), whereas LDCT-CONV<sub>auto</sub> achieved good agreement (weighted κ = 0.792 [95% CI, 0.731-0.847]). Deep learning-based conversion of LDCT images originally obtained with thin slices and a sharp kernel can enhance the accuracy of automated coronary artery calcium score measurement using the images.

Deep-Learning Based Contrast Boosting Improves Lesion Visualization and Image Quality: A Multi-Center Multi-Reader Study on Clinical Performance with Standard Contrast Enhanced MRI of Brain Tumors

Pasumarthi, S., Campbell Arnold, T., Colombo, S., Rudie, J. D., Andre, J. B., Elor, R., Gulaka, P., Shankaranarayanan, A., Erb, G., Zaharchuk, G.

medrxiv logopreprintJun 13 2025
BackgroundGadolinium-based Contrast Agents (GBCAs) are used in brain MRI exams to improve the visualization of pathology and improve the delineation of lesions. Higher doses of GBCAs can improve lesion sensitivity but involve substantial deviation from standard-of-care procedures and may have safety implications, particularly in the light of recent findings on gadolinium retention and deposition. PurposeTo evaluate the clinical performance of an FDA cleared deep-learning (DL) based contrast boosting algorithm in routine clinical brain MRI exams. MethodsA multi-center retrospective database of contrast-enhanced brain MRI images (obtained from April 2017 to December 2023) was used to evaluate a DL-based contrast boosting algorithm. Pre-contrast and standard post-contrast (SC) images were processed with the algorithm to obtain contrast boosted (CB) images. Quantitative performance of CB images in comparison to SC images was compared using contrast-to-noise ratio (CNR), lesion-to-brain ratio (LBR) and contrast enhancement percentage (CEP). Three board-certified radiologists reviewed CB and SC images side-by-side for qualitative evaluation and rated them on a 4-point Likert scale for lesion contrast enhancement, border delineation, internal morphology, overall image quality, presence of artefacts, and changes in vessel conspicuity. The presence, cause, and severity of any false lesions was recorded. CB results were compared to SC using Wilcoxon signed rank test for statistical significance. ResultsBrain MRI images from 110 patients (47 {+/-} 22 years; 52 Females, 47 Males, 11 N/A) were evaluated. CB images had superior quantitative performance than SC images in terms of CNR (+634%), LBR (+70%) and CEP (+150%). In the qualitative assessment CB images showed better lesion visualization (3.73 vs 3.16) and had better image quality (3.55 vs 3.07). Readers were able to rule out all false lesions on CB by using SC for comparison. ConclusionsDeep learning based contrast boosting improves lesion visualization and image quality without increasing contrast dosage. Key ResultsO_LIIn a retrospective study of 110 patients, deep-learning based contrast boosted (CB) images showed better lesion visualization than standard post-contrast (SC) brain MRI images (3.73 vs 3.16; mean reader scores [4-point Likert scale]) C_LIO_LICB images had better overall image quality than SC images (3.55 vs 3.07) C_LIO_LIContrast-to-noise ratio, Lesion-to-brain Ratio and Contrast Enhancement Percentage for CB images were significantly higher than SC images (+729%, +88% and +165%; p < 0.001) C_LI Summary StatementDeep-learning based contrast boosting achieves better lesion visualization and overall image quality and provides more contrast information, without increasing the contrast dosage in contrast-enhanced brain MR protocols.

Protocol of the observational study STRATUM-OS: First step in the development and validation of the STRATUM tool based on multimodal data processing to assist surgery in patients affected by intra-axial brain tumours

Fabelo, H., Ramallo-Farina, Y., Morera, J., Pineiro, J. F., Lagares, A., Jimenez-Roldan, L., Burstrom, G., Garcia-Bello, M. A., Garcia-Perez, L., Falero, R., Gonzalez, M., Duque, S., Rodriguez-Jimenez, C., Hernandez, M., Delgado-Sanchez, J. J., Paredes, A. B., Hernandez, G., Ponce, P., Leon, R., Gonzalez-Martin, J. M., Rodriguez-Esparragon, F., Callico, G. M., Wagner, A. M., Clavo, B., STRATUM,

medrxiv logopreprintJun 13 2025
IntroductionIntegrated digital diagnostics can support complex surgeries in many anatomic sites, and brain tumour surgery represents one of the most complex cases. Neurosurgeons face several challenges during brain tumour surgeries, such as differentiating critical tissue from brain tumour margins. To overcome these challenges, the STRATUM project will develop a 3D decision support tool for brain surgery guidance and diagnostics based on multimodal data processing, including hyperspectral imaging, integrated as a point-of-care computing tool in neurosurgical workflows. This paper reports the protocol for the development and technical validation of the STRATUM tool. Methods and analysisThis international multicentre, prospective, open, observational cohort study, STRATUM-OS (study: 28 months, pre-recruitment: 2 months, recruitment: 20 months, follow-up: 6 months), with no control group, will collect data from 320 patients undergoing standard neurosurgical procedures to: (1) develop and technically validate the STRATUM tool, and (2) collect the outcome measures for comparing the standard procedure versus the standard procedure plus the use of the STRATUM tool during surgery in a subsequent historically controlled non-randomized clinical trial. Ethics and disseminationThe protocol was approved by the participant Ethics Committees. Results will be disseminated in scientific conferences and peer-reviewed journals. Trial registration number[Pending Number] ARTICLE SUMMARYO_ST_ABSStrengths and limitations of this studyC_ST_ABSO_LISTRATUM-OS will be the first multicentre prospective observational study to develop and technically validate a 3D decision support tool for brain surgery guidance and diagnostics in real-time based on artificial intelligence and multimodal data processing, including the emerging hyperspectral imaging modality. C_LIO_LIThis study encompasses a prospective collection of multimodal pre, intra and postoperative medical data, including innovative imaging modalities, from patients with intra-axial brain tumours. C_LIO_LIThis large observational study will act as historical control in a subsequent clinical trial to evaluate a fully-working prototype. C_LIO_LIAlthough the estimated sample size is deemed adequate for the purpose of the study, the complexity of the clinical context and the type of surgery could potentially lead to under-recruitment and under-representation of less prevalent tumour types. C_LI

Beyond Benchmarks: Towards Robust Artificial Intelligence Bone Segmentation in Socio-Technical Systems

Xie, K., Gruber, L. J., Crampen, M., Li, Y., Ferreira, A., Tappeiner, E., Gillot, M., Schepers, J., Xu, J., Pankert, T., Beyer, M., Shahamiri, N., ten Brink, R., Dot, G., Weschke, C., van Nistelrooij, N., Verhelst, P.-J., Guo, Y., Xu, Z., Bienzeisler, J., Rashad, A., Flügge, T., Cotton, R., Vinayahalingam, S., Ilesan, R., Raith, S., Madsen, D., Seibold, C., Xi, T., Berge, S., Nebelung, S., Kodym, O., Sundqvist, O., Thieringer, F., Lamecker, H., Coppens, A., Potrusil, T., Kraeima, J., Witjes, M., Wu, G., Chen, X., Lambrechts, A., Cevidanes, L. H. S., Zachow, S., Hermans, A., Truhn, D., Alves,

medrxiv logopreprintJun 13 2025
Despite the advances in automated medical image segmentation, AI models still underperform in various clinical settings, challenging real-world integration. In this multicenter evaluation, we analyzed 20 state-of-the-art mandibular segmentation models across 19,218 segmentations of 1,000 clinically resampled CT/CBCT scans. We show that segmentation accuracy varies by up to 25% depending on socio-technical factors such as voxel size, bone orientation, and patient conditions such as osteosynthesis or pathology. Higher sharpness, isotropic smaller voxels, and neutral orientation significantly improved results, while metallic osteosynthesis and anatomical complexity led to significant degradation. Our findings challenge the common view of AI models as "plug-and-play" tools and suggest evidence-based optimization recommendations for both clinicians and developers. This will in turn boost the integration of AI segmentation tools in routine healthcare.
Page 64 of 2252246 results
Show
per page

Ready to Sharpen Your Edge?

Join hundreds of your peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.